Status:
RECRUITING
Key Interventions to Improve the Follow-up Adherence Post Cervical Precancerous Lesion Treatment in Ethiopia
Lead Sponsor:
Addis Ababa University
Conditions:
Suspicious Cervical Cancer Lesions Follow up Adherence
Eligibility:
FEMALE
25-49 years
Phase:
NA
Brief Summary
The goal of this pragmatic randomized control trial is to evaluate the effectiveness of three interventions in improving follow-up adherence among women treated for suspicious cervical lesions in prim...
Eligibility Criteria
Inclusion
- Women aged 30-49 (HIV-negative).
- Women over 25 (HIV-positive).
- Treated for suspicious cervical lesions after a positive VIA screening.
Exclusion
- History of hysterectomy.
- Diagnosis of other histological invasive cervical cancer.
- Suspicious cervical cancer cases.
- Pregnancy.
- Prior screening history.
- Vaginal bleeding.
- Lack of consent.
Key Trial Info
Start Date :
November 20 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 30 2025
Estimated Enrollment :
466 Patients enrolled
Trial Details
Trial ID
NCT06515301
Start Date
November 20 2024
End Date
December 30 2025
Last Update
June 10 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Worabe Health Center
Silte, Southern Ethiopia, Ethiopia